Simultaneous measurement of ATP release and LTA does not potentiate platelet aggregation to epinephrine

Marie Lordkipanidzé; Gillian C. Lowe; Steve P. Watson; on behalf of the UK GAPP study group

doi:10.1160/TH13-02-0123

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2013; 110(01): 199-201
DOI: 10.1160/TH13-02-0123

Letters to the Editor

Schattauer GmbH

Simultaneous measurement of ATP release and LTA does not potentiate platelet aggregation to epinephrine

Marie Lordkipanidzé^*

¹Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

,

Gillian C. Lowe^*

¹Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

,

Steve P. Watson

¹Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

,

on behalf of the UK GAPP study group

References
1 Hayward CP, Moffat KA, Castilloux JF. et al. Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder. Thromb Haemost 2012; 107: 726-734.
2 Harrison P, Mackie I, Mumford A. et al. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155: 30-44.
3 Pai M, Wang G, Moffat KA. et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 2011; 136: 350-358.
4 Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 1987; 70: 620-623.
5 Dawood BB, Lowe GC, Lordkipanidzé M. et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood 2012; 120: 5041-5049.
6 Callan MB, Shofer FS, Wojenski C. et al. Chronolume and magnesium potentiate aggregation of canine but not human platelets in citrated plateletrich plasma. Thromb Haemost 1998; 80: 176-180.
7 Mehta P, Mehta J, Ostrowski N. et al. Potentiation of platelet aggregation by Chronolume. Thromb Res 1983; 32: 509-512.
8 Zwierzina WD, Kunz F. A method of testing platelet aggregation in native whole blood. Thromb Res 1985; 38: 91-100.
9 Pfueller SL, Broadway M. Inhibition of platelet aggregation and [14C] serotonin release by luciferin: luciferase preparations. Thromb Res 1986; 44: 539-542.
10 Thompson NT, Scrutton MC. Inhibition by luciferin-luciferase reagents of aggregatory responses to excitatory agonists in washed platelet suspensions. Thromb Res 1985; 38: 109-119.
11 Nash CA, Severin S, Dawood BB. et al. Src family kinases are essential for primary aggregation by G(i) -coupled receptors. J Thromb Haemost 2010; 08: 2273-2282.